Page last updated: 2024-09-02

carboxyamido-triazole and Cachexia

carboxyamido-triazole has been researched along with Cachexia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Ye, CY; Zhang, DC; Zhu, L	1

Other Studies

1 other study(ies) available for carboxyamido-triazole and Cachexia

Article	Year
Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:4 Topics: Adipose Tissue; Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Sirtuin 1; Triazoles; Tumor Burden; Tumor Necrosis Factor-alpha	2017

Article

Year

Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.

Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:4

Topics: Adipose Tissue; Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Sirtuin 1; Triazoles; Tumor Burden; Tumor Necrosis Factor-alpha

2017